Evaluating the Effects of Selective Treatment Utilizing Flex-dosing for Unresectable HCC with Y90 SIR-Spheres

CompletedOBSERVATIONAL
Enrollment

1

Participants

Timeline

Start Date

January 8, 2021

Primary Completion Date

October 18, 2024

Study Completion Date

October 18, 2024

Conditions
Hepatocellular Carcinoma
Interventions
PROCEDURE

SIRT with Y-90 resin microspheres

Selective internal radiation therapy (SIRT) with Y-90 resin microspheres (Y-90 resin SIRT) is an intra-arterial, catheter-based locoregional therapy that has been used to treat patients with unresectable HCC

Trial Locations (1)

75203

Methodist Dallas Medical Center, Dallas

All Listed Sponsors
lead

Methodist Health System

OTHER